507 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with HCV/HIV co-infection: Results from the aids pegasys ribavirin international co-infectio (abstract withdrawn)
Year: 2004
Type: article
Source: Journal of Hepatology
Authors: M. Rodriguez-Torres, F.J. Torriani, E. Lissen, N. Brau, M. Sulkowski, R. Sola, B. Clotet, N. Clumeck, D. Cooper, D. Dieterich
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2080556785
